Your browser doesn't support javascript.
The clinical and genomic epidemiology of seasonal human coronaviruses in congregate homeless shelter settings: A repeated cross-sectional study.
Chow, Eric J; Casto, Amanda M; Rogers, Julia H; Roychoudhury, Pavitra; Han, Peter D; Xie, Hong; Mills, Margaret G; Nguyen, Tien V; Pfau, Brian; Cox, Sarah N; Wolf, Caitlin R; Hughes, James P; Uyeki, Timothy M; Rolfes, Melissa A; Mosites, Emily; Shim, M Mia; Duchin, Jeffrey S; Sugg, Nancy; Starita, Lea A; Englund, Janet A; Chu, Helen Y.
  • Chow EJ; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Casto AM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Rogers JH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Roychoudhury P; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Han PD; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Xie H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Mills MG; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Nguyen TV; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Pfau B; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Cox SN; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Wolf CR; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Hughes JP; Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Uyeki TM; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.
  • Rolfes MA; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
  • Mosites E; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Shim MM; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Duchin JS; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Sugg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Starita LA; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Englund JA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chu HY; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lancet Reg Health Am ; 15: 100348, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-2228942
ABSTRACT

Background:

The circulation of respiratory viruses poses a significant health risk among those residing in congregate settings. Data are limited on seasonal human coronavirus (HCoV) infections in homeless shelter settings.

Methods:

We analysed data from a clinical trial and SARS-CoV-2 surveillance study at 23 homeless shelter sites in King County, Washington between October 2019-May 2021. Eligible participants were shelter residents aged ≥3 months with acute respiratory illness. We collected enrolment data and nasal samples for respiratory virus testing using multiplex RT-PCR platform including HCoV. Beginning April 1, 2020, eligibility expanded to shelter residents and staff regardless of symptoms. HCoV species was determined by RT-PCR with species-specific primers, OpenArray assay or genomic sequencing for samples with an OpenArray relative cycle threshold <22.

Findings:

Of the 14,464 samples from 3281 participants between October 2019-May 2021, 107 were positive for HCoV from 90 participants (median age 40 years, range 0·9-81 years, 38% female). HCoV-HKU1 was the most common species identified before and after community-wide mitigation. No HCoV-positive samples were identified between May 2020-December 2020. Adults aged ≥50 years had the highest detection of HCoV (11%) among virus-positive samples among all age-groups. Species and sequence data showed diversity between and within HCoV species over the study period.

Interpretation:

HCoV infections occurred in all congregate homeless shelter site age-groups with the greatest proportion among those aged ≥50 years. Species and sequencing data highlight the complexity of HCoV epidemiology within and between shelters sites.

Funding:

Gates Ventures, Centers for Disease Control and Prevention, National Institute of Health.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Lancet Reg Health Am Year: 2022 Document Type: Article Affiliation country: J.lana.2022.100348

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Lancet Reg Health Am Year: 2022 Document Type: Article Affiliation country: J.lana.2022.100348